110 related articles for article (PubMed ID: 7628832)
1. Reduced beta-adrenergic sensitivity in healthy volunteers induced by hypoglycemia.
Trovik TS; Jaeger R; Jorde R; Sager G
Fundam Clin Pharmacol; 1995; 9(2):181-6. PubMed ID: 7628832
[TBL] [Abstract][Full Text] [Related]
2. Reduced sensitivity to beta-adrenoceptor stimulation and blockade in insulin dependent diabetic patients with hypoglycaemia unawareness.
Trovik TS; Jaeger R; Jorde R; Sager G
Br J Clin Pharmacol; 1994 Nov; 38(5):427-32. PubMed ID: 7893584
[TBL] [Abstract][Full Text] [Related]
3. Reduced beta-adrenergic sensitivity in patients with type 1 diabetes and hypoglycemia unawareness.
Korytkowski MT; Mokan M; Veneman TF; Mitrakou A; Cryer PE; Gerich JE
Diabetes Care; 1998 Nov; 21(11):1939-43. PubMed ID: 9802747
[TBL] [Abstract][Full Text] [Related]
4. Effect of hypoglycemia on beta-adrenergic sensitivity in normal and type 1 diabetic subjects.
Fritsche A; Stumvoll M; Grüb M; Sieslack S; Renn W; Schmülling RM; Häring HU; Gerich JE
Diabetes Care; 1998 Sep; 21(9):1505-10. PubMed ID: 9727899
[TBL] [Abstract][Full Text] [Related]
5. Hypoglycemic symptoms and decreased beta-adrenergic sensitivity in insulin-dependent diabetic patients.
Berlin I; Grimaldi A; Payan C; Sachon C; Bosquet F; Thervet F; Puech AJ
Diabetes Care; 1987; 10(6):742-7. PubMed ID: 2827974
[TBL] [Abstract][Full Text] [Related]
6. Altered cAMP response after isoprenaline stimulation of mononuclear leucocytes from insulin-dependent diabetic patients with hypoglycaemia unawareness.
Trovik TS; Vaartun A; Sager G
Pharmacol Toxicol; 1995 Oct; 77(4):270-5. PubMed ID: 8577639
[TBL] [Abstract][Full Text] [Related]
7. Avoidance of hypoglycemia restores hypoglycemia awareness by increasing beta-adrenergic sensitivity in type 1 diabetes.
Fritsche A; Stefan N; Häring H; Gerich J; Stumvoll M
Ann Intern Med; 2001 May; 134(9 Pt 1):729-36. PubMed ID: 11329230
[TBL] [Abstract][Full Text] [Related]
8. Differences in metabolic responses to beta-adrenergic stimulation after propranolol or metoprolol administration.
William-Olsson T; Fellenius E; Björntorp P; Smith U
Acta Med Scand; 1979; 205(3):201-6. PubMed ID: 218427
[TBL] [Abstract][Full Text] [Related]
9. Dysfunction in the beta 2-adrenergic signal pathway in patients with insulin dependent diabetes mellitus (IDDM) and unawareness of hypoglycaemia.
Trovik TS; Vaartun A; Jorde R; Sager G
Eur J Clin Pharmacol; 1995; 48(5):327-32. PubMed ID: 8641318
[TBL] [Abstract][Full Text] [Related]
10. The adrenergic contribution to glucose counterregulation in type I diabetes mellitus. Dependency on A-cell function and mediation through beta 2-adrenergic receptors.
De Feo P; Bolli G; Perriello G; De Cosmo S; Compagnucci P; Angeletti G; Santeusanio F; Gerich JE; Motolese M; Brunetti P
Diabetes; 1983 Oct; 32(10):887-93. PubMed ID: 6311652
[TBL] [Abstract][Full Text] [Related]
11. Reversal of hypoglycemia unawareness in a long-term type 1 diabetic patient by improvement of beta-adrenergic sensitivity after prevention of hypoglycemia.
Fritsche A; Stumvoll M; Häring HU; Gerich JE
J Clin Endocrinol Metab; 2000 Feb; 85(2):523-5. PubMed ID: 10690848
[TBL] [Abstract][Full Text] [Related]
12. Suspected postprandial hypoglycemia is associated with beta-adrenergic hypersensitivity and emotional distress.
Berlin I; Grimaldi A; Landault C; Cesselin F; Puech AJ
J Clin Endocrinol Metab; 1994 Nov; 79(5):1428-33. PubMed ID: 7962339
[TBL] [Abstract][Full Text] [Related]
13. Beta blockade and diabetes mellitus: effect of oxprenolol and metoprolol on the metabolic, cardiovascular, and hormonal response to insulin-induced hypoglycemia in insulin-dependent diabetics.
Viberti GC; Keen H; Bloom SR
Metabolism; 1980 Sep; 29(9):873-9. PubMed ID: 6106149
[TBL] [Abstract][Full Text] [Related]
14. Lack of hypoglycemic symptoms and decreased beta-adrenergic sensitivity in insulin-dependent diabetic patients.
Berlin I; Grimaldi A; Landault C; Zoghbi F; Thervet F; Puech AJ; Legrand JC
J Clin Endocrinol Metab; 1988 Feb; 66(2):273-8. PubMed ID: 2828405
[TBL] [Abstract][Full Text] [Related]
15. Oral propranolol and metoprolol both impair glucose recovery from insulin-induced hypoglycemia in insulin-dependent diabetes mellitus.
Popp DA; Tse TF; Shah SD; Clutter WE; Cryer PE
Diabetes Care; 1984; 7(3):243-7. PubMed ID: 6376017
[TBL] [Abstract][Full Text] [Related]
16. Higher glycemic thresholds for symptoms during beta-adrenergic blockade in IDDM.
Hirsch IB; Boyle PJ; Craft S; Cryer PE
Diabetes; 1991 Sep; 40(9):1177-86. PubMed ID: 1657673
[TBL] [Abstract][Full Text] [Related]
17. Return of beta-adrenergic sensitivity in a patient with insulinoma after removal of the tumour.
Vea H; Trovik TS; Sager G; Birkeland K; Revhaug A; Sundsfjord J; Jorde R
Diabet Med; 1997 Nov; 14(11):979-84. PubMed ID: 9400924
[TBL] [Abstract][Full Text] [Related]
18. Reduced beta-adrenoceptor sensitivity in the elderly.
Vestal RE; Wood AJ; Shand DG
Clin Pharmacol Ther; 1979 Aug; 26(2):181-6. PubMed ID: 37014
[TBL] [Abstract][Full Text] [Related]
19. Comparison of beta-adrenoceptor selectivity of acebutolol and its metabolite diacetolol with metoprolol and propranolol in normal man.
Thomas MS; Tattersfield AE
Eur J Clin Pharmacol; 1986; 29(6):679-83. PubMed ID: 2872056
[TBL] [Abstract][Full Text] [Related]
20. Mononuclear leukocyte beta 2-adrenergic receptors and adenylate cyclase sensitivity in insulin-dependent diabetes mellitus.
Sérusclat P; Rosen SG; Smith EB; Shah SD; Clutter WE; Cryer PE
Diabetes; 1983 Sep; 32(9):825-9. PubMed ID: 6313456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
